Ayala Pharmaceuticals, Inc. Quarterly Revenue from Contract with Customer, Excluding Assessed Tax in USD from Q4 2017 to Q1 2022

Taxonomy & unit
us-gaap: USD
Description
Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.
Summary
Ayala Pharmaceuticals, Inc. annual/quarterly Revenue from Contract with Customer, Excluding Assessed Tax history and growth rate from Q4 2017 to Q1 2022.
  • Ayala Pharmaceuticals, Inc. Revenue from Contract with Customer, Excluding Assessed Tax for the quarter ending April 30, 2022 was $250K, a 81.8% decline year-over-year.
  • Ayala Pharmaceuticals, Inc. annual Revenue from Contract with Customer, Excluding Assessed Tax for 2022 was $250K, a 92.3% decline from 2021.
  • Ayala Pharmaceuticals, Inc. annual Revenue from Contract with Customer, Excluding Assessed Tax for 2021 was $3.24M, a 1181% increase from 2020.
  • Ayala Pharmaceuticals, Inc. annual Revenue from Contract with Customer, Excluding Assessed Tax for 2020 was $253K, a 98.8% decline from 2019.
Revenue from Contract with Customer, Excluding Assessed Tax, Trailing 12 Months (USD)
Revenue from Contract with Customer, Excluding Assessed Tax, Quarterly (USD)
Revenue from Contract with Customer, Excluding Assessed Tax, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2022 $250K -$1.13M -81.8% Feb 1, 2022 Apr 30, 2022 10-Q 2022-06-08
Q3 2021 $3.24M $0 Aug 1, 2021 Oct 31, 2021 10-K 2023-02-10
Q2 2021 $250K May 1, 2021 Jul 31, 2021 10-Q 2022-09-13
Q1 2021 $1.38M +$1.13M +450% Feb 1, 2021 Apr 30, 2021 10-Q 2022-06-08
Q4 2020 $1.62M +$1.61M +53733% Nov 1, 2020 Jan 31, 2021 10-Q 2022-03-17
Q1 2020 $260K $250K -$938K -79% Feb 1, 2020 Apr 30, 2020 10-Q 2021-06-14
Q4 2019 $1.2M $3K -$19.7M -100% Nov 1, 2019 Jan 31, 2020 10-Q 2021-03-16
Q3 2019 $20.9M $1K -$1.13M -99.9% Aug 1, 2019 Oct 31, 2019 10-K 2021-01-22
Q2 2019 $22M $6K -$1.13M -99.5% May 1, 2019 Jul 31, 2019 10-Q 2020-09-10
Q1 2019 $23.1M $1.19M -$559K -32% Feb 1, 2019 Apr 30, 2019 10-Q 2020-06-11
Q4 2018 $23.7M $19.7M +$17.6M +858% Nov 1, 2018 Jan 31, 2019 10-Q 2020-03-13
Q3 2018 $6.06M $1.13M Aug 1, 2018 Oct 31, 2018 10-K 2019-12-20
Q2 2018 $1.13M May 1, 2018 Jul 31, 2018 10-Q 2019-09-09
Q1 2018 $1.75M Feb 1, 2018 Apr 30, 2018 10-Q 2019-06-10
Q4 2017 $2.06M Nov 1, 2017 Jan 31, 2018 10-Q 2019-03-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.